March #45 : The ABCs of Baby AZT - by Lark Lands

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Dog Days in Malibu

Breathless

Born in Flames

Gay Guru

Soldier of Fortune

Rare Gem

Marathon Man

On the Waterfront

Race With the Angels

Mean Streets

S.O.S.

To the Editor

Ticket to Ride

Death by Disclosure

Slip Off the Old Block

Poster of the Month: Ruff Times

FYI

Say What

HIV in the Hood

No Brownie Points

Grades for AIDS

French Twist

Southern Discomfort

Sister Act Up

Sister Act Up

POZ Biz

POZarazzi: Call It a Day

Verse: Terminal Girl

Primary Concerns

Obits

Naming Names

Fast Company

Junk Mail

Life After Legacy

Spin Doctors

PWAs’ Best Friend

What’s Up, Doc?

HIV’s Incredible Endgame

The ABCs of Baby AZT

Hit the Dirt

Selling Sustiva

Publish or Perish

Best of the Rest

Where to Find It

What a Waste

Full Disclosure

People, Their Pets and Pet Peeves

Parental Guidance

Aunt Evelyn's Letters



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

March 1999

The ABCs of Baby AZT

by Lark Lands

Late may be far better than never when it comes to using AZT to prevent transmission of HIV from mothers to babies. New York researchers report that giving AZT to babies within the first 48 hours of life lowered the transmission rate from the 26.6 percent seen with no treatment to only 9.3 percent, even though the mothers had not taken the drug during pregnancy. When mothers were given the drug during delivery, only 10 percent of the babies became infected. Waiting to start treatment in the babies until day three or later was much less effective, yielding a transmission risk of 18.4 percent. The best results—a transmission rate of only 6.1 percent—were seen when AZT was given to mothers during their pregnancies. The researchers urged efforts to identify all women who did not receive AZT during their pregnancies, so that the med could be given to them during delivery, and to their babies very soon after birth. 



[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.